These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1297917)

  • 1. Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity.
    Elkins KL; Winegar RK; Nacy CA; Fortier AH
    Microb Pathog; 1992 Nov; 13(5):417-21. PubMed ID: 1297917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid generation of specific protective immunity to Francisella tularensis.
    Elkins KL; Leiby DA; Winegar RK; Nacy CA; Fortier AH
    Infect Immun; 1992 Nov; 60(11):4571-7. PubMed ID: 1398969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis.
    Elkins KL; Rhinehart-Jones T; Nacy CA; Winegar RK; Fortier AH
    Infect Immun; 1993 Mar; 61(3):823-9. PubMed ID: 8432603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live vaccine strain of Francisella tularensis: infection and immunity in mice.
    Fortier AH; Slayter MV; Ziemba R; Meltzer MS; Nacy CA
    Infect Immun; 1991 Sep; 59(9):2922-8. PubMed ID: 1879918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
    Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
    Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
    Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
    Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D; Rhinehart-Jones TR; Elkins KL
    J Immunol; 1996 Dec; 157(11):5042-8. PubMed ID: 8943413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal requirements for murine resistance to infection with Francisella tularensis LVS.
    Elkins KL; Rhinehart-Jones TR; Culkin SJ; Yee D; Winegar RK
    Infect Immun; 1996 Aug; 64(8):3288-93. PubMed ID: 8757866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Culkin SJ; Rhinehart-Jones T; Elkins KL
    J Immunol; 1997 Apr; 158(7):3277-84. PubMed ID: 9120284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
    Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host resistance to the LVS strain of Francisella tularensis in BCG vaccinated mice.
    Taplits MS; Myrvik QN
    J Reticuloendothel Soc; 1977 Oct; 22(4):297-308. PubMed ID: 411926
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.